SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Identifying and addressing the social determinants of health (SDOH) influences health outcomes and can positively impact health equity in our society.
Read Moreby Sharmon Osae | Apr 12, 2024 | Commentary | 0
Identifying and addressing the social determinants of health (SDOH) influences health outcomes and can positively impact health equity in our society.
Read Moreby Stuart Haines | Mar 29, 2024 | Case Study, Commentary, Panel Discussion | 0
The patient was referred for diabetes management who is not responding to three antihyperglycemic agents. Is adherence with lifestyle and medications the culprit? Of is something else going on?
Read Moreby Gregory Castelli | Mar 15, 2024 | Commentary | 0
Mortality attributable to obesity is caused by many secondary conditions like metabolic disorders and cardiovascular (CV) disease. Enter the glucagon-like peptide-1 (GLP-1) receptor agonists which induce significant weight loss. But can a weight loss drug decrease CV mortality?
Read Moreby stefania cian | Mar 2, 2024 | Commentary | 0
Pharmacists are the most accessible health professionals and can play a vital role in screening and managing hypertension. But would an expanded scope of practice be cost-effective?
Read Moreby Molly Corder | Feb 16, 2024 | Commentary | 0
Proton Pump Inhibitors are widely used and often used for years. Does long-term use increase the risk of developing dementia?
Read Moreby Vincent Lam | Feb 2, 2024 | Commentary | 0
Most clinical settings now use oscillometric BP devices to measure patients’ BP, and over half of people with hypertension (HTN) use a home BP monitor. Can we trust these BP readings if an inappropriate cuff size was used?
Read Moreby Alicia Nordberg-Payne | Jan 20, 2024 | Commentary | 0
While heart failure with preserved ejection fraction (HFpEF) accounts for at least 50% of all heart failure cases, effective pharmacotherapy to improve outcomes and symptoms remains limited. Over 75% of HFpEF patients have a comorbid diagnosis of obesity.
Read Moreby Laura Lerner | Jan 5, 2024 | Commentary | 0
As people living with HIV age, the risk of cardiovascular disease becomes the greatest threat to their health and quality of life. But does statin therapy reduce ASCVD risk in patients living with HIV?
Read Moreby Laura Knockel | Dec 19, 2023 | Commentary | 3
Respiratory syncytial virus (RSV) is a common respiratory virus that cause mild symptoms in most but has the potential to hospitalize and kill many older adults and infants. Two RSV vaccines became available in 2023.
Read Moreby Sabrina Silveira | Dec 1, 2023 | Case Study, Commentary, Panel Discussion | 0
Chief Complaint: My medication is making my mouth dry. I want to stop it.
Read Moreby Kaitlyn Phillips | Nov 20, 2023 | Commentary | 0
Can supplements marketed for cardiovascular health be used in place of statin therapy? he SPORT trial attempts to provide robust data on how common supplements perform compared to statin therapy.
Read Moreby Elizabeth Yett | Nov 6, 2023 | Commentary | 1
Do pharmacists providing remote care to patients with hypertension perform as well as physicians and care managers providing care face-to-face? Is BP control better (or worse)? What about patient satisfaction?
Read MoreiForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.